Home Cellular science StartUPDATES: New developments from healthcare startups

StartUPDATES: New developments from healthcare startups



HealthMine, a technology-based member engagement and rewards company focused on empowering members to take the right steps to improve their health, announced a partnership with ReferWell, a healthcare technology company that drives effective care transitions down to the last mile.

This partnership will enhance the HealthMine member app to include seamless appointment scheduling in the app, filling the most critical gaps in care and rewarding members for their healthy actions. Click here to read the full announcement.

Encellin, a personalized regenerative medicine biotechnology company developing new cellular approaches to deliver sustainable single-implant therapies, announced the closing of a $ 5.9 million seed funding round last week. Khosla Ventures and SV Latam Capital co-led the tour with participation from Sandhill Angels and Y Combinator.

The new funding will be used to advance the development of its technology platform and its hypoglycemia and hypocalcemia programs. It will also be used to fit out the laboratory and expand the team. Encellin will also expand into areas with renewable cell sources and readily available artificial cells, to encapsulate any cellular cargo in its proprietary platform products.

Encellin manufactures implantable cell pockets to treat chronic diseases. The technology combines new cell encapsulation technology with functional cell therapies to treat chronic diseases, starting with endocrine disorders. Encellin’s main programs focus on hypoglycemia, the greatest unmet medical need in type 1 diabetes and hypocalcaemia, which affects one-third of dialysis patients.

“This seed funding round led by leading investors allows us to advance the development of our cell encapsulation device in a variety of different indications, starting with chronic endocrine disorders,” said Crystal Nyitray , Ph.D., CEO and co-founder of Encellin. “Our team is bringing together advanced nanotechnology and bioengineering technologies to develop our proprietary Encellin platform which uses known biocompatible materials made in flexible nanoporous pouches to support cell function. We look forward to advancing our pipeline focused on endocrine disorders to harness the power of cells to deliver long-lasting therapies to patients with a single implant. “

To know more, Click here.

Carrum Health has appointed Pallav Sharda as the Chief Platform Manager to lead the evolution of the company’s technology platform as it expands its supplier base and the procedures available to self-insured employers. Sharda brings a unique blend of data science, product management and clinical expertise to Carrum Health, the premier digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology platform for better and more cost-effective surgical care.

“Now is the time to change the way people experience healthcare and I am delighted to welcome a leader of Pallav’s caliber to help advance our technology platform,” said Sach Jain, CEO and Founder by Carrum Health. “With our platform, we virtualized almost every step of a surgical episode through our patient app, while dramatically simplifying the adoption of COE programs for employers. “

Prior to joining Carrum Health, Sharda was global head of healthcare and life sciences for Google Cloud in addition to working on healthcare projects at X, the R&D division of Google’s parent company, Alphabet. He has taught post-graduate medical informatics courses at Northwestern University. He has also served as Director of Advanced Analytics for Kaiser Permanente and Director of HIE Product Management for UnitedHealth Group.

A physician by training, Sharda received a master’s degree in bioinformatics from Columbia University and spent the first part of her career working in IT product management and healthcare engineering for GE Healthcare. In addition, he was Director of Interoperability and Partnerships at Omnicell and co-founded healthcare IT startup Dovetail Care Inc.

Hydrogen Health, a joint venture between Anthem and K Health backed by Blackstone, added former Anthem Customer Director Brad Kirkpatrick as Chief Commercial Officer. The goal of the joint venture is to simplify access to primary care, including chronic, acute and preventive care.

Her dissertation includes expanding existing partnerships, adding employers and insurance partners, and collaborating on solutions to generate value for employers and health plans.

“Primary care is the cornerstone of improving health and healthcare costs, but 30-50% of the self-insured employer population has no primary care relationship. Employers want better digital access for employees, ”Kirkpatrick said. “It’s a business imperative to embrace new models of healthcare, and Hydrogen is uniquely positioned to offer the best technology, the best medical talent and the expertise to make the changes that are needed. “

Prior to Hydrogen, Kirkpatrick served as Chief Customer Officer for WebMD.

To know more, Click here.

Woebot’s health, a health tech company that develops digital therapies for mental health, has hired Kim Goodwin as vice president of user experience. Prior to Woebert Health, Goodwin was a consultant for Medtronic, Best Buy, and Boeing. She has also held leadership roles at PatientsLikeMe and with strategy and design firm Cooper.

Hiring follows $ 90 Million Series B Funding Round Last Month, which said it will accelerate the development of its platform and technologies, advance its leading digital therapy candidates, and expand its team and go-to-market activities. Woebot also received revolutionary device designation for its digital therapeutics designed to treat postpartum depression.

To know more, Click here.

Photo: akindo, Getty Images